Pharmaceuticals, Biotechnology and Life Sciences
Former Chief Medical Officer of Blade Therapeutics and Genentech Group Medical Director to lead Recursion’s clinical development programs SALT LAKE…
Jake Simson, Ph.D., joins Board of Directors Financing proceeds will support the progression of the Company’s first-in-class, oral IL-17 antagonist…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive…
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced that it has received approval of an additional…
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC (“Monroe”) today announced it acted as sole lead arranger and administrative agent on the funding of…
UK MHRA authorization is based on a rolling review of COVID-19 Vaccine Moderna data, including data from the Phase 3…
DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application,…
DUBLIN–(BUSINESS WIRE)–The “Biosimilar Therapeutic Peptides Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering. Rituximab…
Announces New Oral HBV RNA Destabilizer, EDP-721, as an Additional Component Toward Functional HBV Cure; Expects to Initiate Phase 1…